News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
The essential bacterial guanosine triphosphatase FtsZ was validated as a target for antibacterial intervention by British researchers from Prolysis in Oxfordshire and the University of Sheffield. FtsZ is a bacterial homologue of mammalian β-tubulin that initiates cell division by polymerising and then assembling into a ring.
The substance PC190723 prevents cell division and was used as inhibitor of FtsZ. It showed potent and selective bactericidal activity against staphylococci in vitro, including methicillin- and multi-drug–resistant strains of Staphylococcus aureus and succeeded in curing mice infected with a lethal dose of S. aureus in an in vivo model of infection.
The putative inhibitor-binding site of PC190723 could be mapped to a region of FtsZ that is analogous to the Taxol-binding site of tubulin.
The putative inhibitor-binding site of PC190723 could be mapped to a region of FtsZ that is analogous to the Taxol-binding site of tubulin.
Related antibodies on antibodies-online.com:
Staphylococcus aureus (methicillin resistant)
Antibodies for the research area bacteria: »Show antibodies
Antibodies for the research area cell cycle: »Show antibodies
Antibodies for the research area drugs: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

